D. I. Annear
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antimicrobial Resistance in Staphylococcus 18
-
- Bacterial biofilms and quorum sensing 7
- Biochemical and Structural Characterization 4
- Co-authors
- W.B. Grubb (16 shared papers)John W. Pearman (2 shared papers)C. S. Goodwin (1 shared paper)Jim Warren (1 shared paper)Barry J. Marshall (1 shared paper)John A. Armstrong (1 shared paper)Brian J. Mee (1 shared paper)M. E. Bailey (1 shared paper)
- Journals
- The Medical Journal of Australia (15 papers)Immunology and Cell Biology (14 papers)The Lancet (6 papers)Pathology (5 papers)Nature (4 papers)
- Partner nations
- AustraliaUnited Kingdom
In The Last Decade
D. I. Annear
61 papers receiving 752 citations
Peers
Comparison fields: 5 of 101
- Clinical Biochemistry 132
- Infectious Diseases 338
- Molecular Medicine 62
- Biotechnology 104
- Endocrinology 55
Countries citing papers authored by D. I. Annear
This map shows the geographic impact of D. I. Annear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. I. Annear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. I. Annear more than expected).
Fields of papers citing papers by D. I. Annear
This network shows the impact of papers produced by D. I. Annear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. I. Annear. The network helps show where D. I. Annear may publish in the future.
Co-authors
The 14 scholars most cited alongside D. I. Annear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Original isolation of Campylobacter pyloridis from human gastric mucosa | 1984 | 220 |
| 2 | 1968 | 118 | |
| 3 | 1976 | 49 | |
| 4 | 1956 | 37 | |
| 5 | 1968 | 31 | |
| 6 | 1986 | 30 | |
| 7 | 1972 | 30 | |
| 8 | 1962 | 28 | |
| 9 | 1972 | 23 | |
| 10 | 1958 | 16 | |
| 11 | 1984 | 16 | |
| 12 | 1984 | 16 | |
| 13 | 1985 | 15 | |
| 14 | 1972 | 14 | |
| 15 | 1958 | 14 | |
| 16 | 1954 | 12 | |
| 17 | 1976 | 12 | |
| 18 | 1969 | 12 | |
| 19 | 1962 | 11 | |
| 20 | 1974 | 11 |
About D. I. Annear
D. I. Annear is a scholar working on Infectious Diseases, Molecular Biology, Biotechnology, Clinical Biochemistry and Epidemiology, having authored 63 papers that have together received 915 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (18 papers), Microbial Metabolism and Applications (11 papers), Bacterial Identification and Susceptibility Testing (9 papers), Bacterial biofilms and quorum sensing (7 papers), Streptococcal Infections and Treatments (4 papers), Biochemical and Structural Characterization (4 papers), Mycobacterium research and diagnosis (4 papers) and Listeria monocytogenes in Food Safety (4 papers). The work is most often cited by research in Clinical Biochemistry (132 citations), Infectious Diseases (338 citations), Molecular Medicine (62 citations), Biotechnology (104 citations) and Endocrinology (55 citations). D. I. Annear has collaborated with scholars based in Australia and United Kingdom. Frequent co-authors include W.B. Grubb, John W. Pearman, C. S. Goodwin, Jim Warren, Barry J. Marshall, John A. Armstrong, Brian J. Mee, M. E. Bailey, N. Ashdown and B. H. Laurence. Their work appears in journals such as The Medical Journal of Australia, Immunology and Cell Biology, The Lancet, Pathology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.